Pfizer has many talented scientists and some of the very best R&D leaders in the industry. It also sells truly innovative drugs, such as the cancer meds Xalkori, Inlyta and Ibrance and the vaccine Prevnar. It is one of the heaviest R&D spenders in the industry, with $8.4 billion invested in 2014, and over $80 billion over the last 10 years. Its scientists have been resourceful. They were the first to experiment with virtual clinical trials, and to embed themselves amongst leading academic researchers to tap cutting-edge science and turn it into successful drugs. In short, Pfizer has had all the ingredients it needed to succeed: talent, scientific leadership, boldness, resources, and the courage to try what hasn’t been done before.
from Forbes - Leadership http://ift.tt/1l2dOsW
No comments:
Post a Comment